Last reviewed · How we verify
NCT05550311
Robot-Assisted Rehabilitation in Individuals With Stroke
NA trial testing Robot-assisted rehabilitation in Stroke in 34 participants. Completed in 15 October 2023.
1 October 2023
Quick facts
| Lead sponsor | Biruni University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 34 |
| Start date | 15 November 2022 |
| Primary completion | 1 October 2023 |
| Estimated completion | 15 October 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Robot-assisted rehabilitation
- Conventional rehabilitation
Conditions studied
- Stroke — all drugs for Stroke →
Sponsor
Biruni University
Who can join
Adults 18 to 65, any sex, with Stroke. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Stroke has a high rate of morbidity and mortality worldwide. This disease is the third leading cause of death after ischemic heart disease and cancer. Stroke is also the leading cause of disability in adults. It is known that stroke individuals have not only limb restriction, but also respiratory capacity and exercise capacity. It has been shown in the literature that upper extremity functions are directly related to respiratory capacity. Although it is known that upper extremity training has positive effects on respiratory capacity in stroke individuals, more studies are needed to examine the effects of upper extremity robot-assisted rehabilitation on respiratory capacity. The aim of this study is to examine the effects of upper extremity robot-assisted rehabilitation applied in addition to conventional treatment on respiratory parameters, dyspnea, and functional capacity.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of upper extremity robotic rehabilitation on respiratory parameters, functional capacity and dyspnea in patients with stroke: a randomized controlled study.
Okumuş B, Akıncı B, Aytutuldu GK, Baran MS. · · 2025 · cited 2× · PMID 39527236 · DOI 10.1007/s10072-024-07868-z
Verify or expand the search:
- PubMed search for NCT05550311
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stroke
Currently open trials in the same condition.
- NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
- NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
- NCT07356011 — Exoskeleton for Balance · NA · recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting
Other Biruni University trials
Trials by the same sponsor.
- NCT07509762 — Exercise Programs in Women With PCOS · NA · not yet recruiting
- NCT07499843 — Synchronous vs. Asynchronous Telerehabilitation for High-Risk Infants · NA · not yet recruiting
- NCT07495540 — Comparison of the Effects of Free Weight and Machine-Based Exercises on Muscular Parameters · NA · not yet recruiting
- NCT07452328 — Postural Stability and Trunk Strength in Wrestlers · not yet recruiting
- NCT07467525 — Neuromuscular Effects of Acute Fatigue in Adolescent Basketball · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05550311 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Biruni University
- Last refreshed: 29 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05550311.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing